The Molecular and Cellular Basis of Tumor Rejection After Vaccination With Mammary Adenocarcinoma Cells Transduced With the MHC Class II Transactivator CIITA

被引：0
|
作者：
Lorenzo Mortara
Paola Castellani
Raffaella Meazza
Giovanna Tosi
Andrea De Lerma Barbaro
Francesco A Procopio
Luciano Zardi
Silvano Ferrini
Roberto S Accolla
机构：
[1] University of Insubria,Department of Clinical and Biological Sciences, School of Medicine
[2] Istituto Nazionale per la Ricerca sul Cancro,Laboratory of Cellular Biology
[3] Istituto Nazionale per la Ricerca sul Cancro,Laboratory of Immunopharmacology
[4] Advanced Biotechnology Center,Philogen
来源：
Retrovirology | / 2卷
关键词：
ELISPOT Assay; Vaccination Protocol; Massive Necrosis; Mammary Adenocarcinoma Cell; Syngeneic Recipient;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response
    Ramesh Ekkirala, Chaitanya
    Cappello, Paola
    Accolla, Roberto S.
    Giovarelli, Mirella
    Romero, Irene
    Garrido, Cristina
    Miguel Garcia-Lora, Angel
    Novelli, Francesco
    PANCREAS, 2014, 43 (07) : 1066 - 1072
  • [22] Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA
    Lüder, CGK
    Lang, C
    Giraldo-Velasquez, M
    Algner, M
    Gerdes, J
    Gross, U
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 134 (1-2) : 12 - 24
  • [23] The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (ClITA)
    Tosi, G
    Pilotti, E
    Barbaro, ADL
    Mortara, L
    Casoli, C
    Accolla, RS
    TISSUE ANTIGENS, 2005, 66 (05): : 343 - 343
  • [24] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    J Mark Sloan
    Michael H Kershaw
    Christopher E Touloukian
    Rejean Lapointe
    Paul F Robbins
    Nicholas P Restifo
    Patrick Hwu
    Cancer Gene Therapy, 2002, 9 : 946 - 950
  • [25] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    Sloan, JM
    Kershaw, MH
    Touloukian, CE
    Lapointe, R
    Robbins, PF
    Restifo, NP
    Hwu, P
    CANCER GENE THERAPY, 2002, 9 (11) : 946 - 950
  • [26] MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells
    Sloan, JM
    Kershaw, M
    Lapointe, R
    Robbins, P
    Restifo, N
    Hwu, P
    FASEB JOURNAL, 2001, 15 (05): : A1202 - A1202
  • [27] Tumor cells transduced with the MHC class II transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain
    Thompson, JA
    Dissanayake, SK
    Ksander, BR
    Knutson, KL
    Disis, ML
    Ostrand-Rosenberg, S
    CANCER RESEARCH, 2006, 66 (02) : 1147 - 1154
  • [28] Antigen presentation to CD4 T-cells by hepatocytes from mice transgenic for the MHC class II transactivator (CIITA).
    Jagemann, B
    Henninger, J
    Blessing, M
    Lohse, AW
    HEPATOLOGY, 2000, 32 (04) : 300A - 300A
  • [29] IFN-γ up-regulates expression of the MHC class II transactivator (CIITA) type IV promoter in multiple myeloma cells
    Piskurich, Janet F.
    Zhao, Mojun
    Flynt, Frederick L.
    Hong, Mei
    Chen, Han
    Gilbert, Carolyn A.
    Briley, Nicole T.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [30] IL-27 Activates MHC Class II Expression in Intestinal Epithelial Cells via STAT1-Dependent Class II Transactivator (CIITA) Induction
    Diegelmann, Julia
    Brand, Stephan
    GASTROENTEROLOGY, 2012, 142 (05) : S865 - S865
12345